Author(s): Eschwege E, Basdevant A, Crine A, Moisan C, Charles MA
Abstract Share this page
Abstract AIM: This analysis estimates the prevalence of type 2 diabetes mellitus (T2DM) in French adults participating in the ObEpi (obesity epidemiology) 2012 survey and also proposes a description of that population, according to comorbidities, treatments and sociodemographic factors related to the disease. METHODS: A self-administered questionnaire was posted to 20,000 households from the Kantar Health panel. In total, 25,714 adults aged≥18 years and representative of the French population completed the survey between January and March 2012. RESULTS: The prevalence of T2DM was 5.5±0.3\% (95\% CI) in this representative sample of the adult French population. Average age of patients was 65.9 years; 55\% were men. Mean body mass index was 29.9kg/m(2) (men: 29.4kg/m(2), women: 30.6 kg/m(2); P<0.01); the prevalence of obesity was 43.1\% (men: 39.9\%, women: 47.1\%; P<0.01). Patient-reported treatments for comorbidities were frequent: high blood pressure, 59.1\%; dyslipidaemia, 59.9\%; myocardial infarction/angina pectoris, 9.7\%; revascularization, 7.8\%; heart failure, 7.4\%; sleep apnoea, 8.3\%; and osteoarthritis, 10.7\%. With regards to known treatments, 81.4\% of patients were taking oral antidiabetic drugs (OADs), and 15.3\% were using insulin therapy. Also, 18.8\% of diabetic respondents reported financial hardship. CONCLUSION: T2DM remains a disease of major concern: compared with the non-diabetic population, all parameters surveyed showed unfavourable ratings, particularly for women. Copyright © 2014 Elsevier Masson SAS. All rights reserved.
This article was published in Diabetes Metab
and referenced in Journal of Proteomics & Bioinformatics